WHO RSV Roadshow Web Event 2

On Tuesday 18th of October we organised in collaboration with WHO and PATH the second Web Event “RSV Clinical Disease and Burden in Infants”.

How does RSV impact infants and young children? Join us for a discussion on the clinical aspects of RSV disease and a deeper dive into disease burden. Learn about what severe RSV disease looks like, how RSV disease is currently managed, and RSV’s pervasive health impacts globally and across regions..

Recording Available

Catch up on our recent web event, ‘RSV Clinical Disease and Burden in Infants’. Watch the full recording below to gain valuable insights from leading experts in the field.

Presentation slides

Thank you to our host and speakers

Prof. Louis Bont

ReSViNET Chairman & University Medical Center Utrecht – Utrecht, The Netherlands

Prof. dr. Louis Bont, specialised in infectious diseases and leads the RSV Research Group at the University Medical Centre Utrecht, the Netherlands. Prof. Bont is also chairman of the ReSViNET foundation and supervises RSV related studies, such as the RSV GOLD mortality study (funded by the Bill & Melinda Gates Foundation).

Prof. MD Janet Englund

Pediatrics at the University of Washington, Seattle Children’s Hospital – Seattle, Washington

Janet Englund is Professor of Pediatrics at the University of Washington, Seattle Children’s Hospital in Seattle, Washington, and affiliate investigator at Fred Hutch Cancer Center. Dr. Englund is actively studying respiratory viral vaccines in diverse populations, including infants, children, immunocompromised persons, and pregnant persons, as well as evaluating viral diagnostics, antiviral resistance, and novel antiviral therapy. Her research group has participated in studies of COVID-19, influenza, and RSV vaccines, monoclonal antibodies, and maternal immunization. She directs the Seattle site of the CDC-sponsored New Vaccine Surveillance Network.

Dr. Prof. You Li

Epidemiology at Nanjing Medical University -Nanjing, Jiangsu, China

You Li is a professor of epidemiology at Nanjing Medical University, China and an honorary fellow at University of Edinburgh, UK. Prof. Li leads the Infectious Diseases Epidemiology and Modelling (IDEM) group at Nanjing Medical University. The group conducts research on disease burden, transmission, and prediction of respiratory infectious diseases as well as assessment of the impact of pharmaceutical and non-pharmaceutical interventions. Prof. Li has substantial track records of publications in internationally renowned journals, such as Lancet, Lancet Respiratory Medicine, Lancet Infectious Diseases, Lancet Global Health, Lancet Digital Health, Eurosurveillance, and BMC Medicine.

Dr. Prof. Ziyaad Dangor

Vaccines and Infectious Diseases Analytics Research Unit (VIDA) at the University of the Witwatersrand

Associate Professor Ziyaad Dangor is the clinical research director at the world-renowned Vaccines and Infectious Diseases Analytics Research Unit (VIDA). He also works as a paediatric pulmonologist in the Department of Paediatrics and Child Health at the Chris Hani Baragwanath Academic Hospital. As a researcher, Ziyaad completed his doctoral thesis on the clinical and immunological epidemiology of Group B Streptococcal (GBS) disease. His research focus has been on the burden of infectious diseases in young infants, paediatric lung health, health advocacy and medical education.

Upcoming Events

Web Events Program 2024 – 2025

If you have registered for the first 2 WHO RSV Roadshows you don’t need to register again. You will receive a email with an invitation to a Teams meeting and register only with your name and email address.